SCHEMBL2901672

SCHEMBL2901672

Cc1cc(I)cc(C(=O)N(C2CC2)C2CC2)c1C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.35
S1PR3 Q99500 2/20 0.34
GAA P10253 1/20 0.34
POLB P06746 2/20 0.33
GPR119 Q8TDV5 2/20 0.32
S1PR1 P21453 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905905 0.80 HSD11B1 (0.35) HSD11B1S1PR3GAAPOLBGPR119
SCHEMBL2783257 0.70 TSHR (0.48) HSD11B1POLB
SCHEMBL2901669 0.69 CSNK1E (0.32) POLB
SCHEMBL27107435 0.66 SIRT3 (0.37) GAAPOLB
SCHEMBL11867319 0.64 TTR (0.39) GAA
SCHEMBL2901213 0.62 HSD11B1 (0.40) HSD11B1S1PR3GAAGPR119
SCHEMBL23600938 0.60 CYP3A4 (0.50) POLB
SCHEMBL2381135 0.60 CYP3A4 (0.41) POLB
SCHEMBL2781610 0.60 TSHR (0.49) HSD11B1
SCHEMBL9812889 0.60 S1PR3 (0.53) HSD11B1S1PR3GAAS1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871760-B1 CYANO ANTHRANILAMIDE INSECTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-08-11 EP disclosed
US-7601743-B2 Cyano anthranilamide insecticides SYNGENTA CROP PROTECTION, INC. (US) 2009-10-13 US disclosed
US-20080182750-A1 Cyano Anthranilamide Insecticides SYNGENTA CROP PROTECTION, INC. (US) 2008-07-31 US disclosed
EP-1871760-A1 CYANO ANTHRANILAMIDE INSECTICIDES Syngeta Participations AG (CH) 2008-01-02 EP disclosed
WO-2006111341-A1 CYANO ANTHRANILAMIDE INSECTICIDES SYNGENTA PARTICIPATIONS AG (CH) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182750-A1 Cyano Anthranilamide Insecticides CRY1, CRYAA, ALDH7A1 HSD11B1 1171/4885S1PR3 4762/4885GAA 1327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.